Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain SPPI message board posts where the ticker symbol SPPI has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest SPPI SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-063673 Size: 15 KB
2017-12-04
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0000831547-17-000073 (34 Act)  Size: 10 MB
2017-11-03 001-35006
171176685
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0000831547-17-000069 (34 Act)  Size: 335 KB
2017-11-02 001-35006
171172210
8-K  Documents Current report, items 7.01, 8.01, and 9.01
Acc-no: 0000831547-17-000067 (34 Act)  Size: 53 KB
2017-10-18 001-35006
171142746
8-K  Documents Current report, items 1.01, 3.03, and 9.01
Acc-no: 0000831547-17-000065 (34 Act)  Size: 46 KB
2017-10-13 001-35006
171136772
8-K  Documents Current report, items 3.02, 8.01, and 9.01
Acc-no: 0000831547-17-000061 (34 Act)  Size: 71 KB
2017-10-10 001-35006
171128589
SC 13D/A  Documents [Amend] General statement of acquisition of beneficial ownership
Acc-no: 0001193125-17-298552 (34 Act)  Size: 36 KB
2017-09-29 005-49329
171109016
8-K  Documents Current report, item 8.01
Acc-no: 0000831547-17-000059 (34 Act)  Size: 46 KB
2017-09-29 001-35006
171108989
424B5  Documents Prospectus [Rule 424(b)(5)]
Acc-no: 0000831547-17-000057 (33 Act)  Size: 392 KB
2017-08-04 333-208760
171009426
8-K  Documents Current report, items 1.01 and 9.01
Acc-no: 0000831547-17-000056 (34 Act)  Size: 349 KB
2017-08-04 001-35006
171009405
More SPPI SEC Filings


Related news from
Sun, 17 Dec 2017
23:59:00 +0000
Spectrum Pharmaceuticals Announces Leadership Changes
Spectrum Pharmaceuticals, Inc. , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that its Board of Directors has terminated Rajesh C.
Wed, 13 Dec 2017
12:00:00 +0000
Spectrum Pharmaceuticals Highlights Two Oral Presentations on FOLOTYN® (pralatrexate injection) at the 59th Annual Meeting of the American Society of Hematology (ASH)
Spectrum Pharmaceuticals , a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced two oral presentations of data on FOLOTYN and research progress for the treatment of Peripheral T-Cell Lymphoma at the 59th American Society of Hematology .
Tue, 12 Dec 2017
15:32:23 +0000
Chart in Focus: Spectrum Pharmaceuticals’ Financials
In 3Q17, Spectrum Pharmaceuticals (SPPI) raised $114.0 million from the sale of 12.6 million shares through its security offering program.
Tue, 12 Dec 2017
14:03:32 +0000
An Overview of Spectrum Pharmaceuticals’ Drug Pipeline
Spectrum Pharmaceuticals (SPPI) obtained exclusive rights to commercialize Poziotinib from Hanmi Pharmaceutical (HANPF) under an in-license agreement in 2015.
Tue, 12 Dec 2017
12:33:29 +0000
Spectrum Pharmaceuticals’ Product Licensing Agreements
In 2012, Spectrum Pharmaceuticals (SPPI) acquired the rights to market Zevalin outside the US from Bayer for 19 million euros.
Mon, 11 Dec 2017
22:10:02 +0000
A Look at Spectrum Pharmaceuticals’ Recent Acquisitions
Spectrum Pharmaceuticals (SPPI) acquired Talon Therapeutics in July 2013 for $11.3 million in cash and an issuance of 3.0 million shares.
Mon, 11 Dec 2017
20:36:19 +0000
Analysts’ Recommendations for Spectrum Pharmaceuticals
Biotech firm Spectrum Pharmaceuticals (SPPI) develops oncology and hematology drug products. SPPI generates ~90% of its revenues from the US market, and ~10% of its revenues come from Europe.
Mon, 11 Dec 2017
01:44:01 +0000
18 small-cap stocks that analysts expect to rise at least 50% in 2018
They expect four of them to double in price. By Phil van Doorn.
Tue, 05 Dec 2017
15:40:00 +0000
Top 4 Small-Cap Stocks for 2017
Looking at growth outlooks and price targets, these four small-cap stocks could be stellar for the final month of 2017.
Mon, 04 Dec 2017
12:00:00 +0000
Spectrum Pharmaceuticals Highlights 15 Abstracts at the 59th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, Georgia, December 9-12, 2017
Spectrum Pharmaceuticals , a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced key presentations of clinical and scientific data related to its products at the 59th Annual Meeting of the American Society of Hematology , being held in Atlanta, Georgia, from December 9-12, 2017.
Mon, 27 Nov 2017
15:06:03 +0000
Spectrum Doubles in 3 Months: What's Driving the Rally?
Spectrum (SPPI) focuses on developing pipeline candidates. The stock doubled in the last three months mainly on encouraging data from poziotinib study.
Mon, 20 Nov 2017
19:41:15 +0000
Edited Transcript of SPPI earnings conference call or presentation 2-Nov-17 8:30pm GMT
Q3 2017 Spectrum Pharmaceuticals Inc Earnings Call
Sun, 19 Nov 2017
16:43:00 +0000
3 Biotech Stocks to Be Thankful for This Year
If you notice a relative who can't stop grinning at the Thanksgiving dinner table, they're probably holding shares of these biotech stocks.
Fri, 17 Nov 2017
13:10:00 +0000
Today’s Research Reports on Trending Tickers: Spectrum Pharmaceuticals and Myriad Genetics
NEW YORK, NY / ACCESSWIRE / November 17, 2017 / U.S. markets rallied back from the recent two day slump on Thursday on the strength of corporate earnings from Cisco and Wal-Mart. The Dow Jones Industrial ...
Mon, 13 Nov 2017
12:50:00 +0000
Featured Company News - Infinity Shares Clinical and Translational Data from Monotherapy Dose-Escalation Component of Phase-1/1b Study for IPI-549
Research Desk Line-up: Spectrum Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / November 13, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ...
Fri, 10 Nov 2017
15:52:03 +0000
Ligand (LGND) Q3 Earnings & Revenues Top, 2017 View Raised
Ligand's (LGND) earnings and revenues beat estimates. Total revenues also rise year over year on the back of higher royalty benefits. The company ups its guidance for 2017.
Wed, 08 Nov 2017
21:30:00 +0000
Stonegate Capital Partners Updates Coverage on Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI)
DALLAS, TX / ACCESSWIRE / November 8, 2017 / Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI): COMPANY DESCRIPTION Spectrum Pharmaceuticals, Inc. is focused on the acquisition, development and commercialization ...
Wed, 08 Nov 2017
16:00:00 +0000
Why Spectrum Pharmaceuticals Stock Soared in October
Spectrum's preliminary lung cancer data sparked a noteworthy rally in its shares last month.
Wed, 08 Nov 2017
12:00:00 +0000
Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2017 London Healthcare Conference on November 15th
Spectrum Pharmaceuticals, Inc.  , a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the Jefferies 2017 London Healthcare Conference being held at the Waldorf Hilton in London.
Tue, 07 Nov 2017
12:40:00 +0000
Recent Analysis Shows Philip Morris, Danaher, Skechers, Sally Beauty, Spectrum Pharma, and Textron Market Influences – Renewed Outlook, Key Drivers of Growth
NEW YORK, Nov. 07, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Philip ...



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "VF has been a blessing to me and my family. Even if you are not a big contributor, the information is there for you to read. It is amazing that the fine members of VF will openly help and provide ideas to enhance each others investing." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2017, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards